bioMérieux has invested in Allergen Alert, a startup focused on rapid food allergen detection, enhancing food safety for individuals with allergies.

Information on the Target

bioMérieux has recently acquired a stake in Allergen Alert, an innovative startup focused on rapidly detecting food allergens for consumers and professionals. This France-based company is developing a portable, swift, and reliable solution that can promptly identify the presence of allergens and gluten in food, significantly contributing to food safety for those with allergies or celiac disease. Allergen Alert aims to enhance the quality of life for allergy sufferers by reducing their risk of exposure to allergens.

Having launched in 2024, Allergen Alert specializes in food allergen detection, utilizing an advanced technology licensed from bioMérieux. This innovative instrument can analyze food samples and deliver results quickly through a smartphone application, ensuring that both restaurant owners and individual consumers can make informed dining choices.

Industry Overview in France

The food safety and allergen detection market in France is experiencing growth, largely due to increasing awareness of food allergies among the population. Currently, approximately 6% of the European population suffers fro